These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 9853920

  • 21. Vascular endothelial growth factor and basic fibroblast growth factor in patients with squamous cell oesophageal cancer.
    Wallner G, Ciechański A, Dabrowski A, Kozłowski M, Roliński J, Laudański J, Cwik G.
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():122-3. PubMed ID: 11820569
    [Abstract] [Full Text] [Related]

  • 22. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer.
    Feldman AL, Tamarkin L, Paciotti GF, Simpson BW, Linehan WM, Yang JC, Fogler WE, Turner EM, Alexander HR, Libutti SK.
    Clin Cancer Res; 2000 Dec; 6(12):4628-34. PubMed ID: 11156212
    [Abstract] [Full Text] [Related]

  • 23. Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma.
    Edgren M, Lennernäs B, Larsson A, Kälkner KM.
    Anticancer Res; 2001 Dec; 21(2B):1423-9. PubMed ID: 11396226
    [Abstract] [Full Text] [Related]

  • 24. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
    Dhar DK, Ono T, Yamanoi A, Soda Y, Yamaguchi E, Rahman MA, Kohno H, Nagasue N.
    Cancer; 2002 Nov 15; 95(10):2188-95. PubMed ID: 12412173
    [Abstract] [Full Text] [Related]

  • 25. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.
    Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM.
    Clin Cancer Res; 1996 Oct 15; 2(10):1679-84. PubMed ID: 9816116
    [Abstract] [Full Text] [Related]

  • 26. Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors.
    Miyashita M, Tajiri T, Yanagi K, Shimizu T, Futami R, Sasajima K, Tokunaga A.
    Hepatogastroenterology; 2003 Oct 15; 50(50):308-9. PubMed ID: 12749209
    [Abstract] [Full Text] [Related]

  • 27. Vascular endothelial growth factor in chronic subdural haematomas.
    Shono T, Inamura T, Morioka T, Matsumoto K, Suzuki SO, Ikezaki K, Iwaki T, Fukui M.
    J Clin Neurosci; 2001 Sep 15; 8(5):411-5. PubMed ID: 11535006
    [Abstract] [Full Text] [Related]

  • 28. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus.
    Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.
    Lupus; 2002 Sep 15; 11(6):348-55. PubMed ID: 12139372
    [Abstract] [Full Text] [Related]

  • 29. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F, Spagnoli A, Basciani F, Tumini S, Mezzetti A, Cipollone F, Cuccurullo F, Morgese G, Verrotti A.
    Diabet Med; 2000 Sep 15; 17(9):650-6. PubMed ID: 11051284
    [Abstract] [Full Text] [Related]

  • 30. Increased angiogenic growth factor in cyanotic congenital heart disease.
    Himeno W, Akagi T, Furui J, Maeno Y, Ishii M, Kosai K, Murohara T, Kato H.
    Pediatr Cardiol; 2003 Sep 15; 24(2):127-32. PubMed ID: 12360391
    [Abstract] [Full Text] [Related]

  • 31. Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms.
    Sasaki H, Yukiue H, Kobayashi Y, Nakashima Y, Moriyama S, Kaji M, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y.
    Surg Today; 2001 Sep 15; 31(11):1038-40. PubMed ID: 11766079
    [Abstract] [Full Text] [Related]

  • 32. Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes.
    Blann AD, Belgore FM, McCollum CN, Silverman S, Lip PL, Lip GY.
    Clin Sci (Lond); 2002 Feb 15; 102(2):187-94. PubMed ID: 11834138
    [Abstract] [Full Text] [Related]

  • 33. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma.
    Balsari A, Maier JA, Colnaghi MI, Ménard S.
    Lab Invest; 1999 Jul 15; 79(7):897-902. PubMed ID: 10418830
    [Abstract] [Full Text] [Related]

  • 34. Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.
    Keyes KA, Mann L, Cox K, Treadway P, Iversen P, Chen YF, Teicher BA.
    Cancer Chemother Pharmacol; 2003 Apr 15; 51(4):321-7. PubMed ID: 12721760
    [Abstract] [Full Text] [Related]

  • 35. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H, Wierzbowska A, Robak T.
    Eur Cytokine Netw; 2003 Apr 15; 14(1):40-51. PubMed ID: 12799213
    [Abstract] [Full Text] [Related]

  • 36. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.
    Dirix LY, Vermeulen PB, Pawinski A, Prové A, Benoy I, De Pooter C, Martin M, Van Oosterom AT.
    Br J Cancer; 1997 Apr 15; 76(2):238-43. PubMed ID: 9231925
    [Abstract] [Full Text] [Related]

  • 37. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy.
    Andrys C, Borska L, Pohl D, Fiala Z, Hamakova K, Krejsek J.
    Arch Dermatol Res; 2007 Mar 15; 298(10):479-83. PubMed ID: 17221216
    [Abstract] [Full Text] [Related]

  • 38. Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodelling in a Type II diabetic rat model.
    Jesmin S, Sakuma I, Hattori Y, Fujii S, Kitabatake A.
    Diabetologia; 2002 Mar 15; 45(3):402-15. PubMed ID: 11914746
    [Abstract] [Full Text] [Related]

  • 39. [Coexpression of VEGF and bFGF is associated with increased vascular density in head and neck carcinomas].
    Riedel F, Götte K, Schwalb J, Bergler W, Hörmann K.
    Laryngorhinootologie; 2000 Dec 15; 79(12):730-5. PubMed ID: 11199455
    [Abstract] [Full Text] [Related]

  • 40. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY.
    Invest Ophthalmol Vis Sci; 2000 Jul 15; 41(8):2115-9. PubMed ID: 10892852
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.